1-溴-4-甲氧基-2,3-二甲氧基苯 在
镍 作用下,
以
四氢呋喃 为溶剂,
反应 3.0h,
以to afford 871 mg of the title compound as a grey crystalline solid的产率得到3-bromo-6-methoxy-benzene-1,2-diamine
A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof; wherein R1-R7 are as disclosed in the specification and pharmaceutical uses thereof.
公式(I)的化合物或其药物可接受的盐或前药酯;其中R1-R7如说明书所述,及其药物用途。
Quinoxaline derivatives as adenosine receptor antagonists
申请人:MERCK PATENT GMBH
公开号:US11192899B2
公开(公告)日:2021-12-07
The invention relates to quinoxaline derivatives of the general formula I,
and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
本发明涉及通式 I 的喹喔啉衍生物、
以及本发明化合物在治疗和/或预防哺乳动物(尤其是人类)增殖过度或感染性疾病和失调方面的用途,以及含有此类化合物的药物组合物。